Compared to the placebo, the tripeptide infusion reduced mean daily food intake by 27%, decreased fat intake, increased protein intake, and enhanced satiety, while not altering food preferences and sweet taste function
Leveraging data from the National Health and Examination Survey (NHANES), a team of investigators, which included representatives from Harvard, Northwestern, and other leading institutions, concluded 35.0 million adults qualified for use based on its diabetes indication, 129.2 million were eligible based on its weight management indication, and 8.9 million were considered eligible based on its indication for secondary prevention of cardiovascular disease
Cell , (2020)
Some experience redness, itching, or small bumps at the injection site, roughly 5 to 15 percent in studies